RESUMO
Alpinia katsumadai is recorded in Chinese herbal classics of previous dynasties，with a long history of medicinal use and significantly efficacy. This paper made a comprehensive textual research and summarization of the name，origin，distribution of producing areas，genuine producing area，harvesting time，processing method，property and flavor，and treatment functions of A. katsumadai by reviewing the ancient and modern literatures systematically. A. katsumadai has many alias names， such as Doukou，Loukou，Caokou in Chinese. Through the analysis of ancient herbal researches and drawings，it is concluded that there was some disordered uses of A. katsumadai with A. zerumbet and Amomum tsaoko. And the varieties of A. katsumadai have changed in some areas from ancient to present. The original plants of A. katsumadai is Alpinia katsumadai， which belongs to Alpinia of Zingiberaceae in modern textual research. A. katsumadai mainly grows in Lingnan and some other tropical areas； especially， those produced in Hainan have a better quality. The harvest time is usually in summer and autumn when fruits are all ripe. The processing methods of A. katsumadai are various， including heating and bending wrapped with flour， processing slowly with Euodiae Fructus，stir-frying in ancient times，while purifying processing （peeling） is generally used in modern times. A. katsumadai has the effect in invigorating spleen and warming stomach，lower Qi and relieving stagnation-syndrome，drying dampness and driving cold. In modern studies， efforts shall be made to strengthen basic research，establish quantitative standards for processing and digital standard for genuine medicinal materials of A. katsumadai， and deeply explore the compatibility regularity and application of A. katsumadai in ancient prescriptions， in order to ensure the quality and maximize its medicinal value in modern studies.
RESUMO
OBJECTIVE@#To study the clinical effect of alanyl-glutamine-enriched nutritional support in the treatment of children with abdominal Henoch-Schönlein purpura.@*METHODS@#Children with abdominal Henoch-Schönlein purpura who needed nutritional support were enrolled and stratified according to age, sex and the severity of disease, and were randomly divided into a control group (n=118) and an enriched nutritional support group (n=107). The control group was given nutritional support without using alanyl-glutamine, while the enriched nutritional support group was given alanyl-glutamine-enriched nutritional support. Intravenous steroids were used according to the severity of disease in both groups. Other therapies were the same in the two groups. The two groups were compared in terms of the length of hospital stay, the rate and duration of use of intravenous steroids, the recurrence rate of symptoms during hospitalization, the rate of total parenteral nutrition (TPN), the rate of weight loss and the rate of fasting for more than 5 days. All patients were followed up for 3 months after discharge to monitor the recurrence of symptoms.@*RESULTS@#There were no significant differences in the length of hospital stay, the rate of TPN and the rate of fasting for more than 5 days between the two groups (P>0.05). Compared with the enriched nutritional support group, the control group showed significant increases in the rate and duration of use of intravenous steroids, the recurrence rate of symptoms and the rate of weight loss (P<0.05). After the 3-month follow-up, all the children resumed normal diet, and the recurrence rate of digestive symptoms was less than 20% in each group. Abdominal pain was the most common symptom (83.33%, 30/36), followed by vomiting and abdominal distention. No digestive hemorrhage was observed. All the symptoms were relieved after symptomatic treatment. No significant difference was found between the two groups in the recurrence rate of digestive symptoms (P=0.693).@*CONCLUSIONS@#Alanyl-glutamine-enriched nutritional support in the treatment of children with abdominal Henoch-Schönlein purpura can reduce the use of intravenous steroids and weight loss, but without impact on the length of hospital stay and post-discharge recurrence.